Udai Banerji
Has grant
NIHR Professor of Molecular Cancer Pharmacology & Honorary Consultant in Medical Oncology
United KingdomResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Translational proteomics to understand and overcome drug resistance to targeted anticancer drugs in KRAS and PIK3CA driven cancers.
Open Date: 2018-10-01
Close Date: 2023-09-01
Grant: Close
A first in class, first in human Phase I clinical trial of the MT1-MMP-directed bicyclic peptide drug conjugate (BDC) BT1718 in solid cancers including NSCLC, sarcoma and TNBC.
Open Date: 2016-12-01
Close Date:
Grant: Close
Preclinical combination studies with AGC kinase inhibitor AT13148 and Bortezomib.
Open Date: 2014-12-01
Close Date: 2015-11-30
Grant: Close
Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents
Open Date: 2013-03-31
Close Date: 2016-08-18
Grant: Close
CRUKDE/12/013: TAX-TORC A Phase I/II multi-centre trial of AZD2014 (dual mTORC1 and mTORC2 inhibitor) combined with weekly paclitaxel in patients with platinum-resistant ovarian, fallopian, or primary peritoneal cancer.
Open Date: 2012-03-01
Close Date: 2017-12-31
Articles (12)
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (7)
Mariangela Figini
Fondazione IRCCS Istituto Nazionale dei Tumori
Rebecca S. Kristeleit
University of Arizona College of Medicine
Chris Corrigan
King’s College London
Sophia Karagiannis
King’s College London
James Spicer
King’s College London
Elena Cojocaru
Oxford University Hospitals NHS Foundation Trust
Chara Stavraka
NIHR Clinical Lecturer
King’s College London
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.